Benlysta (belimumab) is a prescription medication used to treat active systemic lupus erythematosus (SLE) and active lupus nephritis. It can be given as an intravenous (IV) infusion or an injection ...
The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving ...
The FDA approved a 200 mg/mL belimumab autoinjector for pediatric lupus nephritis, enabling at-home administration and reducing clinic visits. Lupus nephritis affects 30-50% of children with SLE, ...
People with lupus often need to use medicines to manage their symptoms. Although there are many oral medicines that treat lupus, some people with more severe symptoms may not get enough benefit from ...
Benlysta®: What You Need to Know There are different medications available for treating lupus. One option is Benlysta® (belimumab). Below are answers to some of the questions you may have about this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results